source
- Electra Therapeutics raises $350 million in oversubscribed IPOElectra Therapeutics, a South San Francisco biotech focused on inflammation, completed its Nasdaq IPO, selling 23.3 million shares at $15 each and generating $350 million in gross proceeds. This a…
- Biopharma prediction markets raise insider-info concerns, regulators weigh oversightPrediction markets are emerging as platforms where participants can wager on biopharma events such as clinical trial results and FDA approvals. The format allows crowds to aggregate expectations ab…